Neuroleptics and neurologic reactions.
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001264:Athetosis / Q000139:chemically induced; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D005260:Female; D006801:Humans; D008653:Mesoridazine / Q000009:adverse effects; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced*; D009127:Muscle Rigidity / Q000139:chemically induced; D011346:Prochlorperazine / Q000009:adverse effects; D011395:Promazine / Q000009:adverse effects; D013035:Spasm / Q000139:chemically induced; D013064:Speech Disorders / Q000139:chemically induced; D014202:Tremor / Q000139:chemically induced
D014150:Antipsychotic Agents; D008653:Mesoridazine; D011395:Promazine; D011346:Prochlorperazine